Aya Jakobovits - 15 Jun 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Director
Signature
/s/ Nick Harvey, Attorney-in-Fact for Aya Jakobovits
Issuer symbol
ACET
Transactions as of
15 Jun 2021
Net transactions value
-$42,919
Form type
4
Filing time
17 Jun 2021, 18:08:36 UTC
Previous filing
20 May 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $21,465 -1,924 -0.88% $11.16 215,883 15 Jun 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $21,454 -1,923 -0.88% $11.16 215,883 15 Jun 2021 See Footnote F1, F2, F4
holding ACET Common Stock 329,199 15 Jun 2021 See Footnote F5
holding ACET Common Stock 135,799 15 Jun 2021 See Footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary.
F4 Shares held in a trust of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits child is the beneficiary.
F5 Shares held in a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary.
F6 Shares held in a GRAT of which Dr. Jakobovits spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary.